On ECHEMI
Home > Drugs > Hainan Bikai Pharmaceutical Co., Ltd.
Hainan Bikai Pharmaceutical Co., Ltd.
  • Founded in:

    1993-03-22
  • Country:

    China China
  • Address:

    No. 10, Yaogu 1st Road, Haikou National High-tech Industrial Development Zone, Hainan Province
  • Tax NO.:

    91460100284031692C
  • Registered Funds:

    20 million yuan
  • Website:

  • Email:

Related Drugs
Ciprofloxacin Hydrochloride Suppository
Ciprofloxacin hydrochloride
Name Description Content CAS NO. Registered Holders
Ciprofloxacin hydrochloride

This product is a broad-spectrum antibacterial drug, but it is weak against molds and anaerobic bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product is a broad-spectrum antibacterial drug, but it is weak against molds and anaerobic bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

93107-08-5 37
Ergotamine Mesylate Dispersible Tablets
Ergotamine mesylate
Name Description Content CAS NO. Registered Holders
Dihydroergotoxine mesylate

This product is an equal mixture of three dihydrogen derivatives of ergot alkaloids. It has a strong α receptor blocking effect and a central sympathetic nerve blocking effect, which can dilate blood vessels, lower blood pressure, slow heart rate, and reduce myocardial excitability; it can inhibit the body temperature regulation center and the reflex vasoconstriction caused by cold.

More

This product is an equal mixture of three dihydrogen derivatives of ergot alkaloids. It has a strong α receptor blocking effect and a central sympathetic nerve blocking effect, which can dilate blood vessels, lower blood pressure, slow heart rate, and reduce myocardial excitability; it can inhibit the body temperature regulation center and the reflex vasoconstriction caused by cold.

8067-24-1 13
Dihydroergotamine mesylate injection
Dihydroergoceptin mesylate is composed of equal proportions of dihydroergocornine mesylate, dihydroergocryptine mesylate (there are two isomers, dihydro-α-ergocryptine mesylate and dihydro-β-ergocryptine mesylate, in a ratio of 2:1) and dihydroergoline mesylate.
Name Description Content CAS NO. Registered Holders
Dihydroergotoxine mesylate

It changes the central nervous system signal transmission, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors, and a blocking effect on α-adrenergic receptors; it improves the damaged brain metabolic function, which is reflected in the changes in brain electrical activity (such as electroencephalogram); it shortens the cerebral circulation time; it improves age-related intellectual decline symptoms (such as self-care, social behavior, emotional state and intellectual behavior); it stabilizes cerebral vascular tension and prevents migraines.

More

It changes the central nervous system signal transmission, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors, and a blocking effect on α-adrenergic receptors; it improves the damaged brain metabolic function, which is reflected in the changes in brain electrical activity (such as electroencephalogram); it shortens the cerebral circulation time; it improves age-related intellectual decline symptoms (such as self-care, social behavior, emotional state and intellectual behavior); it stabilizes cerebral vascular tension and prevents migraines.

8067-24-1 13
Dihydroergotamine mesylate injection
Dihydroergoceptin mesylate is composed of equal proportions of dihydroergocornine mesylate, dihydroergocryptine mesylate (there are two isomers, dihydro-α-ergocryptine mesylate and dihydro-β-ergocryptine mesylate, in a ratio of 2:1) and dihydroergoline mesylate.
Name Description Content CAS NO. Registered Holders
Dihydroergotoxine mesylate

It changes the signal transmission of the central nervous system, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors, has a blocking effect on α-adrenergic receptors, improves damaged brain metabolic function, shortens cerebral circulation time, improves symptoms of intellectual decline, stabilizes cerebral vascular tension, and prevents migraines.

More

It changes the signal transmission of the central nervous system, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors, has a blocking effect on α-adrenergic receptors, improves damaged brain metabolic function, shortens cerebral circulation time, improves symptoms of intellectual decline, stabilizes cerebral vascular tension, and prevents migraines.

8067-24-1 13
Dihydroergocornine mesylate

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

More

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

0
Dihydroergocryptine mesylate

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

More

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

0
Dihydro-α-ergocryptine mesylate

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

More

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

0
Dihydro-β-ergocryptine mesylate

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

More

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

0
Dihydroergoline mesylate

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

More

Animal tests have shown that this product can change central nervous system signal transmission, and there is evidence that it has an agonist effect on dopamine receptors and 5-hydroxytryptamine receptors; and a blocking effect on α-adrenergic receptors. It can improve damaged brain metabolic function, which reflects changes in brain electrical activity, especially the EEG spectrum. The beneficial effect on the EEG has been confirmed by human trials. This product can also shorten cerebral circulation time. Controlled clinical trials have shown that this product can improve intellectual decline, especially many symptoms of age-related intellectual decline, such as self-care, social behavior, emotional state and intellectual behavior. This product has the effect of stabilizing cerebral vascular tension, which is why it has a preventive effect on migraine.

0
Dihydroergotamine mesylate injection
Dihydroergoceptin mesylate is composed of equal proportions of dihydroergocornine mesylate, dihydroergocryptine mesylate (there are two isomers, dihydro-α-ergocryptine mesylate and dihydro-β-ergocryptine mesylate, in a ratio of 2:1) and dihydroergoline mesylate.
Name Description Content CAS NO. Registered Holders
Dihydroergotoxine mesylate

It changes the central nervous system signal transmission, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors; has a blocking effect on α-adrenergic receptors; improves damaged brain metabolic function; shortens cerebral circulation time; improves age-related intellectual decline symptoms; stabilizes cerebral vascular tension and prevents migraines.

More

It changes the central nervous system signal transmission, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors; has a blocking effect on α-adrenergic receptors; improves damaged brain metabolic function; shortens cerebral circulation time; improves age-related intellectual decline symptoms; stabilizes cerebral vascular tension and prevents migraines.

8067-24-1 13
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.